Anti-factor XA levels in critically ill trauma patients treated for venous thromboembolism with enoxaparin.

被引：0
|
作者：
Sing, R
Barrett, MC
Huynh, T
Miles, W
Jacobs, D
Thomason, M
Rutherford, EJ
机构：
[1] Carolinas Med Ctr, Charlotte, NC 28203 USA
[2] Wake Forest Univ, Raleigh, NC USA
来源：
CRITICAL CARE MEDICINE | 2005年 / 33卷 / 12期
关键词：
D O I：
10.1097/00003246-200512002-00601
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A170 / A170
页数：1
相关论文
共 50 条
  • [41] WEIGHT- AND ANTI-XA-GUIDED ENOXAPARIN PROTOCOL FOR VTE PROPHYLAXIS IN CRITICALLY ILL TRAUMA PATIENTS
    Bigos, Rachel
    Solomon, Edmond
    Dorfman, Jon
    Ha, Michael
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [42] Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
    Wagner, Jonas
    Wruck, Henrike
    Lautenbach, Anne
    von Kroge, Philipp
    Wolter, Stefan
    Mann, Oliver
    Izbicki, Jakob
    Dupree, Anna
    [J]. OBESITY SURGERY, 2022, 32 (03) : 861 - 867
  • [43] ANTI-XA MONITORING OF WEIGHT-BASED ENOXAPARIN FOR VTE PROPHYLAXIS IN CRITICALLY ILL TRAUMA PATIENTS
    Taylor, Ashley
    Huang, Ellen
    Waller, Jennifer
    White, Cassandra
    Robinson, Tim
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [44] Supraprophylactic Anti-Factor Xa Levels Are Associated with Major Bleeding in Neurosurgery Patients Receiving Prophylactic Enoxaparin
    May, Casey C.
    Cua, Santino
    Smetana, Keaton S.
    Powers, Ciaran J.
    [J]. WORLD NEUROSURGERY, 2022, 157 : E357 - E363
  • [45] Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
    Jonas Wagner
    Henrike Wruck
    Anne Lautenbach
    Philipp von Kroge
    Stefan Wolter
    Oliver Mann
    Jakob Izbicki
    Anna Duprée
    [J]. Obesity Surgery, 2022, 32 : 861 - 867
  • [46] Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis
    Marshall, Amanda M.
    Trussell, Taylor M.
    Yee, Addison M.
    Malone, Mathew P.
    [J]. THROMBOSIS RESEARCH, 2021, 203 : 117 - 120
  • [47] ANTI-FACTOR XA ACTIVITY IN NON-WEIGHT BASED ENOXAPARIN DOSING FOR VTE PROPHYLAXIS IN TRAUMA PATIENTS
    Chapman, Scott
    Irwin, Eric
    Bischoff, James
    Thunselle, Matthew
    Beilman, Gregory
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [48] ENOXAPARIN PROPHYLAXIS DOSE ADJUSTED BY ANTI-XA TROUGH LEVELS IN CRITICALLY INJURED TRAUMA PATIENTS
    Roth, Jennifer
    Vaughan, Nathan
    Alaidroos, Imaan
    Rainey, Evan Elizabeth
    Roden-Foreman, Jacob
    Powers, Mark
    Garrett, John
    Foreman, Michael
    [J]. CRITICAL CARE MEDICINE, 2018, 46 (01) : 773 - 773
  • [49] Anti-factor Xa profiles in cardiac patients receiving enoxaparin therapy.
    Tse, ME
    Mak, M
    Mitani, GH
    Pickens, P
    Beringer, PM
    Tesoro, JT
    Sarma, R
    Louie, S
    [J]. PHARMACOTHERAPY, 2005, 25 (10): : 1437 - 1437
  • [50] Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity
    Freeman, Andrew
    Horner, Tuesdy
    Pendleton, Robert C.
    Rondina, Matthew T.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (07) : 740 - 743
12345